Javascript must be enabled to continue!
Autoimmune Hashimoto’s Thyroiditis and Hypothyroidism: Novel Aspects
View through CrossRef
Autoimmune Hashimoto’s thyroiditis is an organ specific autoimmune disorder. It affects the thyroid gland and it is characterized by the presence of antibodies to thyroid proteins, namely, thyroid peroxidase, TPOab and thyroglobulin, Tgab and thyroid tissue invasion by lymphocytes. The presence of Hashimoto’s thyroiditis may be associated with normal thyroid function or hypothyroidism. In many cases of Hashimoto’s thyroiditis with normal thyroid function may progress to subclinical hypothyroidism or overt hypothyroidism. Risk factors for the development of Hashimoto’s thyroiditis are genetic and environmental. Genetic factors are HLA-DR4, CD40, CTLA-4 and PTP-N22 and genetic factors related to thyroglobulin gene and TSH receptor gene. Environmental factors include the presence of iodine excess in the environment, infectious agents such as hepatitis C virus and the SARS-CoV-2 virus, smoking, alcohol, selenium deficiency, drugs such as amiodarone, interferon-a, highly active antiretroviral therapy and immune checkpoint inhibitors. Female sex is also a risk factor for Hashimoto’s thyroiditis. The disease runs a variable course. Presently there are experimental efforts to pause or reverse the autoimmune process which leads to Hashimoto’s thyroiditis and may progress to the destruction of the thyroid gland. Hypothyroidism is treated by the administration of thyroxine usually for life.
Title: Autoimmune Hashimoto’s Thyroiditis and Hypothyroidism: Novel Aspects
Description:
Autoimmune Hashimoto’s thyroiditis is an organ specific autoimmune disorder.
It affects the thyroid gland and it is characterized by the presence of antibodies to thyroid proteins, namely, thyroid peroxidase, TPOab and thyroglobulin, Tgab and thyroid tissue invasion by lymphocytes.
The presence of Hashimoto’s thyroiditis may be associated with normal thyroid function or hypothyroidism.
In many cases of Hashimoto’s thyroiditis with normal thyroid function may progress to subclinical hypothyroidism or overt hypothyroidism.
Risk factors for the development of Hashimoto’s thyroiditis are genetic and environmental.
Genetic factors are HLA-DR4, CD40, CTLA-4 and PTP-N22 and genetic factors related to thyroglobulin gene and TSH receptor gene.
Environmental factors include the presence of iodine excess in the environment, infectious agents such as hepatitis C virus and the SARS-CoV-2 virus, smoking, alcohol, selenium deficiency, drugs such as amiodarone, interferon-a, highly active antiretroviral therapy and immune checkpoint inhibitors.
Female sex is also a risk factor for Hashimoto’s thyroiditis.
The disease runs a variable course.
Presently there are experimental efforts to pause or reverse the autoimmune process which leads to Hashimoto’s thyroiditis and may progress to the destruction of the thyroid gland.
Hypothyroidism is treated by the administration of thyroxine usually for life.
Related Results
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Clinical Significance Of Co-Existance Of Hashimoto Thyroiditis (HT) With Differentiated Thyroid Cancer (DTC)
Clinical Significance Of Co-Existance Of Hashimoto Thyroiditis (HT) With Differentiated Thyroid Cancer (DTC)
Abstract
Background
Hashimoto's Thyroiditis represents a long-term autoimmune condition which ordinarily develops in people diagnosed with Differentiated Thyroid C...
Connecting The Dots: The Impact Of Subclinical Hypothyroidism On Female Subfertility And Obesity
Connecting The Dots: The Impact Of Subclinical Hypothyroidism On Female Subfertility And Obesity
Objective: To find the frequency of subclinical hypothyroidism in females with subfertility
Methods: This was a descriptive cross-sectional study Department of Obstetrics and Gynec...
relationship between vitamin D and TPO antibody in Hashimoto's thyroiditis
relationship between vitamin D and TPO antibody in Hashimoto's thyroiditis
Introduction: Hashimoto's thyroiditis is autoimmune disease that effect on thyroid gland tissue via penetration some special white blood cells (called lymphocyte) into thyroid glan...
Comparison between CRP Level and Some Biochemical Parameters in Hashimoto and Hypothyroidism Iraqi Patients
Comparison between CRP Level and Some Biochemical Parameters in Hashimoto and Hypothyroidism Iraqi Patients
Background: Hypothyroidism is a common medical condition that occurs due to a lack of the hormone thyroxine. Hashimoto's thyroiditis (HT) is the most prevalent thyroid disorder, al...
POLYMORPHOUS LIGHT ERUPTION AND ITS ASSOCIATION WITH HYPOTHYROIDISM AND AUTOIMMUNE THYROIDITIS – A COMPARATIVE CROSS-SECTIONAL STUDY
POLYMORPHOUS LIGHT ERUPTION AND ITS ASSOCIATION WITH HYPOTHYROIDISM AND AUTOIMMUNE THYROIDITIS – A COMPARATIVE CROSS-SECTIONAL STUDY
BACKGROUND In many parts of the world, polymorphous light eruption (PLE) is the commonest cause of
photosensitivity. Previous studies have suggested the association of PLE with mul...
CYTOLOGICAL, ULTRASOUND AND BIOCHEMICAL CORRELATION IN HASHIMOTO’S THYROIDITIS, FARIDABAD, INDIA: A RETROSPECTIVE CROSS-SECTIONAL ANALYSIS.
CYTOLOGICAL, ULTRASOUND AND BIOCHEMICAL CORRELATION IN HASHIMOTO’S THYROIDITIS, FARIDABAD, INDIA: A RETROSPECTIVE CROSS-SECTIONAL ANALYSIS.
Background
Hashimoto’s thyroiditis, an autoimmune disorder that impairs thyroid hormone production via antibody-mediated destruction of thyroid cells, affects women more frequently...
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Abstract
Introduction
Hypothyroidism is a common endocrine disorder, in which the management involves daily intake of thyroxine. However, adherence to a daily medication regimen po...

